AVITA Medical, Inc. (NASDAQ: RCEL) reported Q3 EPS of ($0.34), $0.10 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.4 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.